| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 440 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 112 |
| 2 | ADALIMUMAB | 93 |
| 3 | METHOTREXATE SODIUM | 92 |
| 4 | RISEDRONATE SODIUM | 91 |
| 5 | METHOTREXATE | 85 |
| 6 | PREDNISONE | 84 |
| 7 | ETANERCEPT | 77 |
| 8 | FOLIC ACID | 66 |
| 9 | LEFLUNOMIDE | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 112 | 0.0404 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 2 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 2 | 0.0045 |
| 3 | ALENDRONATE SODIUM | 440 | 0.0043 |
| 4 | ORPHENADRINE CITRATE | 2 | 0.0032 |
| 5 | RISEDRONATE SODIUM | 91 | 0.0029 |
| 6 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 7 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 8 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 9 | NAPROXEN SODIUM 220MG | 30 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin D [EPC] | 180 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 2 | Corticosteroid [EPC] | 112 |
| 3 | Vitamin C [EPC] | 100 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 85 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 80 |
| 6 | Vitamin B12 [EPC] | 78 |
| 7 | Antirheumatic Agent [EPC] | 61 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 58 |
| 9 | Provitamin D2 Compound [EPC] | 58 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 58 | 0.0019 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Calcitonin [EPC] | 3 | 0.0010 |
| 3 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 4 | Vitamin D [EPC] | 180 | 0.0006 |
| 5 | Antirheumatic Agent [EPC] | 61 | 0.0006 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | Interleukin-17A Antagonist [EPC] | 17 | 0.0005 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 58 | 0.0004 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 57 | 0.0004 |